Respiratory Disease Testing Market: Global Industry Analysis and Forecast (2022-2029)

Respiratory Disease Testing Market size is expected to reach US$ 23.39 Bn. by year 2029 at a CAGR of 9.20% during the forecast period.

Respiratory Disease Testing Market Overview:

Respiratory disease testing involves the diagnosis of lungs with any kind of infection and or any tumour or any abnormalities occurring in the lung. This test is also used in the diagnosis of various lung diseases like COPD, Asthma, Lung cancer, Pneumonia, Cough, abnormal breathing rate, congestion, and various others. Respiratory Disease Testing Market To know about the Research Methodology :- Request Free Sample Report

Respiratory Disease Testing Market Dynamics:

The most basic test is spirometry. This test is employed to measure the capacity of the lung that how much air a lung can hold and how forcefully the lung excels the air out of the lung. This test is used to identify the disease that affects lung volume and to identify the disease that affects the airways like Asthma, Chronic Obstructive Pulmonary Diseases COPD. Various diseases affect the lungs and the following tests are carried out like Bronchoscopy, Chest Tube Procedure, CT Scan, CT Scan-Guided Lung Biopsy, Endobronchial Ultrasound (EBUS), Exhaled Nitric Oxide Test, Lobectomy, Lung Function Tests, and various others. Rising pollution in the environment is further boosting the market of respiratory disease testing market. People around the globe have inculcated various bad habits that infect lungs and destroy them internally at a low pace and with time it increases the severity of the disease. For example, smoking and drinking habits affect badly the human body. Moreover, in the US. Around 80-90% of deaths are caused due to cigarette smoking and are added as a major risk factor to the lung. Further, 90% of deaths are occurred in low and middle-income countries due to COPD. Besides, the growing advances in technological investment and in-vitro diagnostic test with the new generation is further boosting the demand of global respiratory disease testing market in the forecast period of 2022-2029. Additionally, growing awareness in an individual due to the digital market is fueling the market and the low purchasing power of an individual can hamper the growth of the market as the diagnostic test are expensive and middle-class families cannot afford this.

Respiratory Disease Testing Market Segment Analysis:

By Product, the segment is divided into Imaging Tests, Respirometers, and Blood Gas Tests. The image test segment is dominating the product segment of the respiratory disease testing market. The image test market is divided into CT scan, X-ray, ultrasound imaging, MRI system, nuclear imaging system, and mammography imaging system. CT scan, X-rays have accounted for a major market share in the region. Due to the clear appearance of infected areas in the lungs and precise diagnosis. The X-ray market was valued at 13.22 billion with a CAGR of 4.7% in the year 2021. Additionally, the medical imaging market is likely to grow at a CAGR of 5.3% and is estimated to reach 28.7 billion in the forecast period of 2022-2029. Growing technological advances, patient importance on effective and early diagnosis, rising occurrence of target diseases together with target drug delivery system, rising preference to low offensive diagnostic procedures, and benefits offered by computed tomography are fueling the market growth of X-ray and CT scan in the market. Moreover, there is the restraining factor responsible to lower the growth like installation of huge machinery together with skilled labors and huge cost investment is anticipated to lower the pace of market growth in the forecast period. Respiratory Disease Testing Market By End-User, the segment is categorized into Hospitals, Physician's Clinics, and Clinical Laboratories. Clinical laboratories are dominating the end-user segment of the global respiratory testing market. The clinical laboratory market was valued at USD 203.3 billion in 2021 and is likely to grow at a 4.9% CAGR in the forecast period. The demand for early diagnosis and the rising occurrence of chronic diseases is fueling the market of clinical laboratories. Rapid innovation in technology like multipurpose imaging machines to diagnose disease together with low-cost investment is likely to boost the market growth of clinical laboratories. North America is leading in the clinical laboratories market due to the adoption of new technologies and innovations. And accounted for 39% of the market share in 2021. Moreover, these technologies are software-based which offers precise diagnostic treatment.

Respiratory Disease Testing Market Regional Insights:

Global Respiratory Diseases Testing Market Regional Insights is segmented into North America, Asia Pacific, Europe, Latin America, Middle East, and Africa. North America is dominating the global respiratory diseases testing market in the regional segment. The technological investment in the region and the demand for cancer treatment are boosting the market as the region has marked a high number of chain smokers. In the US around 6.3% of males and 9.2% of females suffered from asthma in the year 2021. Further 6.4% of people were reported with Chronic Obstructive Pulmonary Disease (COPD) in the US. Hence these factors are fueling the diagnostic treatment of respiratory diseases due to high occurrence in the region. Moreover, the region has high clinical laboratories and service providers that dominated North America. The market player of clinical laboratory service providers is Mayo Medical Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated. The objective of the report is to present a comprehensive analysis of the global Respiratory Disease Testing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global Respiratory Disease Testing Market dynamics, structure by analyzing the market segments and project the global Respiratory Disease Testing Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the global Respiratory Disease Testing Market make the report investor’s guide.

Respiratory Disease Testing Market Scope: Inquire before buying

Global Respiratory Disease Testing Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US$ 11.57 Bn
Forecast Period 2022 to 2029 CAGR: 9.20% Market Size in 2029: US$ 23.39 Bn
Segments Covered: by Product • Imaging test • Respiratory Measurement • Blood gas test • Other
by End-User • Hospitals • Physician clinics • Clinical laboratories • Others

Respiratory Disease Testing Market, by Region

• North America • Europe • Asia Pacific • The Middle East and Africa • South America

Respiratory Disease Testing Market Key Player

• Becton Dickinson (Carefusion Corporation) • Koninklijke Philips N.V.(Respironics) • ResMed Company • Fischer & Paykel • Medtronic • MGC Diagnostics Corporation and Subsidiaries • Carestream Medical Ltd. • Becton Dickinson (Carefusion Corporation) • Koninklijke Philips N.V. (Respironics) • ResMed Company • Abbott • ThermoFisher Scientific • Biomerieux Frequently Asked Questions: 1. Which region has the largest share in Global Respiratory Disease Testing Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Respiratory Disease Testing Market? Ans: The Global Respiratory Disease Testing Market is growing at a CAGR of 9.20% during forecasting period 2022-2029. 3. What is scope of the Global Respiratory Disease Testing market report? Ans: Global Respiratory Disease Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Respiratory Disease Testing market? Ans: The important key players in the Global Respiratory Disease Testing Market are – Becton Dickinson (Carefusion Corporation), Koninklijke Philips N.V.(Respironics), ResMed Company, Fischer & Paykel, Medtronic, MGC Diagnostics Corporation and Subsidiaries, Carestream Medical Ltd., Becton Dickinson (Carefusion Corporation), Koninklijke Philips N.V. (Respironics), ResMed Company, Abbott, ThermoFisher Scientific, and Biomerieux 5. What is the study period of this market? Ans: The Global Respiratory Disease Testing Market is studied from 2021 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Respiratory Disease Testing Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Respiratory Disease Testing Market 3.4. Geographical Snapshot of the Respiratory Disease Testing Market, By Manufacturer share 4. Global Respiratory Disease Testing Market Overview, 2021-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Respiratory Disease Testing Market 5. Supply Side and Demand Side Indicators 6. Global Respiratory Disease Testing Market Analysis and Forecast, 2021-2029 6.1. Global Respiratory Disease Testing Market Size & Y-o-Y Growth Analysis. 7. Global Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 7.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 7.1.1. Imaging test 7.1.2. Respiratory Measurement 7.1.3. Blood gas test 7.1.4. Other 7.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 7.2.1. Hospitals 7.2.2. Physician clinics 7.2.3. Clinical laboratories 7.2.4. Others 8. Global Respiratory Disease Testing Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 9.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 9.1.1. Imaging test 9.1.2. Respiratory Measurement 9.1.3. Blood gas test 9.1.4. Other 9.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 9.2.1. Hospitals 9.2.2. Physician clinics 9.2.3. Clinical laboratories 9.2.4. Others 10. North America Respiratory Disease Testing Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 11.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 11.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 12. Canada Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 12.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 12.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 13. Mexico Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 13.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 13.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 14. Europe Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 14.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 14.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 15. Europe Respiratory Disease Testing Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 16.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 16.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 17. France Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 17.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 17.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 18. Germany Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 18.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 18.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 19. Italy Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 19.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 19.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 20. Spain Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 20.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 20.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 21. Sweden Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 21.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 21.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 22. CIS Countries Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 22.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 22.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 23. Rest of Europe Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 23.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 23.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 24. Asia Pacific Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 24.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 24.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 25. Asia Pacific Respiratory Disease Testing Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 26.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 26.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 27. India Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 27.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 27.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 28. Japan Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 28.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 28.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 29. South Korea Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 29.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 29.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 30. Australia Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 30.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 30.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 31. ASEAN Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 31.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 31.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 32. Rest of Asia Pacific Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 32.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 32.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 33. Middle East Africa Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 33.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 33.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 34. Middle East Africa Respiratory Disease Testing Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 35.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 35.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 36. GCC Countries Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 36.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 36.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 37. Egypt Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 37.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 37.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 38. Nigeria Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 38.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 38.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 39. Rest of ME&A Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 39.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 39.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 40. South America Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 40.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 40.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 41. South America Respiratory Disease Testing Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 42.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 42.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 43. Argentina Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 43.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 43.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 44. Rest of South America Respiratory Disease Testing Market Analysis and Forecasts, 2021-2029 44.1. Market Size (Value) Estimates & Forecast By Products, 2021-2029 44.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Respiratory Disease Testing Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Blackmagic Design Pty. Ltd. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.2. Becton Dickinson (Carefusion Corporation) 45.3.3. Koninklijke Philips N.V.(Respironics) 45.3.4. ResMed Company 45.3.5. Fischer & Paykel 45.3.6. Medtronic 45.3.7. MGC Diagnostics Corporation and Subsidiaries 45.3.8. CAREstream Medical Ltd. 45.3.9. ResMed Company 45.3.10. Abbott 45.3.11. ThermoFisher Scientific 45.3.12. Biomerieux 46. Primary Key Insights

About This Report

Report ID 112641
Category Healthcare
Published Date July 2022
Updated Date
Contact Us